0000880984-22-000007.txt : 20220607
0000880984-22-000007.hdr.sgml : 20220607
20220607201110
ACCESSION NUMBER: 0000880984-22-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Javitt Daniel C.
CENTRAL INDEX KEY: 0001864534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 221002355
MAIL ADDRESS:
STREET 1: 1201 NORTH MARKET STREET
STREET 2: SUITE 111
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-06-03
0
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001864534
Javitt Daniel C.
1201 NORTH MARKET STREET
SUITE 111
WILMINGTON
DE
19801
0
0
1
0
Common Stock
2022-06-03
4
S
0
243596
0.7024
D
12859080
I
by Glytech LLC
Common Stock
2022-06-06
4
S
0
115657
0.6653
D
12743423
I
by Glytech LLC
Common Stock
2022-06-07
4
S
0
86459
0.6461
D
12656964
I
by Glytech LLC
Held by Glytech LLC of which the Reporting Person is the sole owner.
Daniel Javitt
2022-06-07